Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents
Ductal carcinoma in situ of the breast
โ Scribed by Harris, Jules E. ;Bruetman, Daniel ;Bloom, Ken ;Bines, Steven
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 463 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering
MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought